Tdap Vaccine Effectiveness in Adolescents During the 2012 Washington State Pertussis Epidemic

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Pediatrics

• Publication date

  2015-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1542/peds.2014-3358PMID 25941309PMCID PMC5736389
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccine (Tdap) for preventing pertussis: evidence of rapidly waning immunity and difference in effectiveness by Tdap brand.

  2014cited by this paper
• Effectiveness of pertussis vaccines for adolescents and adults: case-control study

  2013cited by this paper
• Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model

  2013cited by this paper
• Prevalence and Molecular Characterization of Pertactin-Deficient Bordetella pertussis in the United States

  2013cited by this paper
• Waning Immunity to Pertussis Following 5 Doses of DTaP

  2013cited by this paper
• Persistence at one year of age of antigen-induced cellular immune responses in preterm infants vaccinated against whooping cough: comparison of three different vaccines and effect of a booster dose.

  2013cited by this paper
• National and State Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2012

  2013cited by this paper
• Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women — Advisory Committee on Immunization Practices (ACIP), 2012

  2013cited by this paper
• Pertactin-negative variants of Bordetella pertussis in the United States.

  2013cited by this paper
• Early Impact of the US Tdap vaccination program on pertussis trends.

  2012cited by this paper
• California pertussis epidemic, 2010.

  2012cited by this paper
• Waning protection after fifth dose of acellular pertussis vaccine in children.

  2012cited by this paper
• National and state vaccination coverage among adolescents aged 13-17 years--United States, 2011.

  2012cited by this paper
• Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010.

  2012cited by this paper
• Pertussis epidemic--Washington, 2012.

  2012cited by this paper
• Different IgG-subclass distributions after whole-cell and acellular pertussis infant primary vaccinations in healthy and pertussis infected children.

  2011cited by this paper
• Barriers to early uptake of tetanus, diphtheria and acellular pertussis vaccine (Tdap) among adults-United States, 2005-2007.

  2011cited by this paper
• Acellular Pertussis Booster in Adolescents Induces Th1 and Memory CD8+ T Cell Immune Response

  2011cited by this paper
• Effectiveness of adolescent and adult tetanus, reduced-dose diphtheria, and acellular pertussis vaccine against pertussis.

  2010cited by this paper
• IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content.

  2009cited by this paper
• PERTUSSIS VACCINE EFFECTIVENESS AFTER MASS IMMUNIZATION OF HIGH SCHOOL STUDENTS IN AUSTRALIA

  2009cited by this paper
• Efficacy of an acellular pertussis vaccine among adolescents and adults.

  2005cited by this paper
• Examination of Universal Vaccine Purchasing States and New Jersey

  2005cited by this paper
• Calling the shots: immunization finance policies and practices. Executive summary of the report of the Institute of Medicine.

  2000cited by this paper
• Protective Immunity to Bordetella pertussis Requires Both B Cells and Cd4+ T Cells for Key Functions Other than Specific Antibody Production

  2000cited by this paper
• Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines

  1997cited by this paper
• All rights reserved

  1997cited by this paper
• Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention.

  1997cited by this paper
• Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP)

  1997cited by this paper
• Morbidity and Mortality Weekly Report Influenza Vaccination of Health-care Personnel Recommendations of the Healthcare Infection Control Practices Advisory Committee (hicpac) and the Advisory Committee on Immunization Practices (acip)

  year unknowncited by this paper

• Pertussis: Modern Approaches to an Ancient Adversary.

  2025cites this paper
• Pertussis Outbreaks: Causes and Consequences

  2025cites this paper
• Pertussis vaccines, epidemiology and evolution

  2024cites this paper
• Assessing the Impact of the 2020 Council of State and Territorial Epidemiologists Case Definition for Pertussis on Reported Pertussis Cases.

  2024cites this paper
• Transplacental transfer of maternal antibodies following immunization with recombinant pertussis vaccines during pregnancy: real-world evidence.

  2024cites this paper
• A reduced-dose recombinant pertussis vaccine booster in Thai adolescents: a phase 2/3, observer-blinded, randomised controlled, non-inferiority trial.

  2024cites this paper
• The durability of vaccine-induced protection: an overview

  2024cites this paper
• High post-exposure prophylaxis (PEP) uptake among household contacts of pertussis patients enrolled in a PEP effectiveness evaluation – United States, 2015–2017

  2023cites this paper
• Chapter Controlled Human Infection with Bordetella pertussis.

  2023cites this paper
• Novel approaches to reactivate pertussis immunity

  2022cites this paper
• Bordetella pertussis in School-Age Children, Adolescents and Adults: A Systematic Review of Epidemiology and Mortality in Europe

  2021cites this paper
• Pertussis Vaccines

  2021cites this paper
• Pertussis (Whooping Cough)

  2021cites this paper
• Lessons from a mature acellular pertussis vaccination program and strategies to overcome suboptimal vaccine effectiveness

  2021cites this paper
• Waning immunity after receipt of Pertussis, Diphtheria, Tetanus and Polio-related vaccines: a systematic review and meta-analysis.

  2021cites this paper
• Pertussis vaccine effectiveness and duration of protection - A systematic review and meta-analysis.

  2021cites this paper
• Economic impact of implementing decennial tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccination in adults in the United States.

  2020cites this paper
• Immunological Distinctions between Acellular and Whole-Cell Pertussis Immunizations of Baboons Persist for at Least One Year after Acellular Vaccine Boosting

  2020cites this paper
• Efficacy, safety, and formulation issues of the combined vaccines

  2020cites this paper
• Exploring childhood vaccination themes and public opinions on Twitter: A semantic network analysis

  2020cites this paper
• Safety and immunogenicity of the epicutaneous reactivation of pertussis toxin immunity in healthy adults: a phase I, randomized, double-blind, placebo-controlled trial.

  2020influential citation
• Impact of population aging on the burden of vaccine-preventable diseases among older adults in the United States

  2020cites this paper
• Toward an Alum Free Mono-Component Monovalent Pertussis Vaccine: A Cytokine Response Assay.

  2020cites this paper
• Vaccine-Preventable Infections in Childcare Workers.

  2020cites this paper
• Optimizing Immunization Strategies in Patients with IBD.

  2020cites this paper
• Tetanus, diphtheria and acellular pertussis (Tdap) vaccine for prevention of pertussis among adults aged 19 years and older in the United States: A cost-effectiveness analysis.

  2020cites this paper
• Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2019

  2020cites this paper
• Effectiveness of acellular pertussis vaccine in older adults: nested matched case-control study.

  2020cites this paper
• The 112-Year Odyssey of Pertussis and Pertussis Vaccines-Mistakes Made and Implications for the Future.

  2019cites this paper
• Adolescent Immunization Schedule: Need for a Relook

  2019cites this paper
• Awareness, Knowledge, and Coverage of Vaccination Against Tetanus, Diphtheria, and Pertussis Among Medical Students of Karachi: A Cross-sectional Analysis

  2019cites this paper
• [Epidemiology of pertussis and prevention strategies: problems and perspectives].

  2019cites this paper
• Human Immune Responses to Pertussis Vaccines.

  2019cites this paper
• Toward a Controlled Human Infection Model of Pertussis.

  2019cites this paper
• A qPCR assay for Bordetella pertussis cells that enumerates both live and dead bacteria

  2019cites this paper
• Acellular pertussis vaccines effectiveness over time: A systematic review, meta-analysis and modeling study

  2018cites this paper
• Assessment of Tdap Vaccination Effectiveness in Adolescents in Integrated Health-Care Systems.

  2018cites this paper
• 44 – Pertussis Vaccines

  2018cites this paper
• On the role of different age groups during pertussis epidemics in California, 2010 and 2014

  2018influential citation
• Effectiveness of acellular pertussis vaccine and evolution of pertussis incidence in the community of Madrid from 1998 to 2015.

  2018cites this paper
• Safety of repeated doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine in adults and adolescents

  2018cites this paper
• Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

  2018cites this paper
• Randomized Controlled Trial of the Safety and Immunogenicity of Revaccination With Tetanus-Diphtheria-Acellular Pertussis Vaccine (Tdap) in Adults 10 Years After a Previous Dose

  2018cites this paper
• On the Role of Different Age Groups and Pertussis Vaccines During the 2012 Outbreak in Wisconsin

  2018cites this paper
• Successful Vaccines.

  2018influential citation
• The Epidemiology of Nationally Reported Pertussis in the United States, 2000-2016.

  2018cites this paper
• Antibody persistence after vaccination of adolescents with monovalent and combined acellular pertussis vaccines containing genetically inactivated pertussis toxin: a phase 2/3 randomised, controlled, non-inferiority trial.

  2018cites this paper
• Recommendations to control pertussis prioritized relative to economies: A Global Pertussis Initiative update.

  2018cites this paper
• Boosting Teenagers With Acellular Pertussis Vaccines Containing Recombinant or Chemically Inactivated Pertussis Toxin: A Randomized Clinical Trial

  2018influential citation
• Lower Sustained Diphtheria and Pertussis Antibody Concentrations in Inflammatory Bowel Disease Patients

  2018cites this paper
• Detection and incidence of Bordetella holmesii in respiratory specimens from patients with pertussis-like symptoms in New South Wales, Australia.

  2018cites this paper
• Immunogenicity and safety of a second booster dose of an acellular pertussis vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after a first booster in adolescence: An open, phase III, non-randomized, multi-center study

  2018influential citation
• Is Tdap the Best Prevention We Have Against Pertussis Disease?

  2018cites this paper
• Geospatial analysis of nonmedical vaccine exemptions and pertussis outbreaks in the United States

  2017cites this paper
• Development of a qualitative assay for screening of Bordetella pertussis isolates for pertussis toxin production

  2017cites this paper
• Summary of Notifiable Infectious Diseases and Conditions - United States, 2015.

  2017cites this paper
• What Is Wrong with Pertussis Vaccine Immunity? Inducing and Recalling Vaccine-Specific Immunity.

  2017cites this paper
• Evaluation of Pertussis Knowledge Within the Child Daycare Staff and Management in the El Paso, Texas

  2017cites this paper
• What Is Wrong with Pertussis Vaccine Immunity? The Problem of Waning Effectiveness of Pertussis Vaccines.

  2017influential citation
• Economic burden of diagnosed pertussis among individuals with asthma or chronic obstructive pulmonary disease in the USA: an analysis of administrative claims

  2017cites this paper
• Impact of vaccine mandate on Tdap vaccination coverage among Illinois students 2014-15

  2017cites this paper
• Use of acellular pertussis vaccines in the United States: can we do better?

  2017cites this paper
• Immune persistence after pertussis vaccination

  2017cites this paper
• Bordetella PlrSR regulatory system controls BvgAS activity and virulence in the lower respiratory tract

  2017cites this paper
• What Is Wrong with Pertussis Vaccine Immunity?

  2017cites this paper
• Reduced Severity of Pertussis in Persons With Age-Appropriate Pertussis Vaccination—United States, 2010–2012

  2017cites this paper
• Pertussis outbreak in Polish shooters with adverse event analysis

  2017cites this paper
• What Is Wrong with Pertussis Vaccine Immunity? Why Immunological Memory to Pertussis Is Failing.

  2017cites this paper
• Strategies To Boost Maternal Immunization To Achieve Further Gains In Improved Maternal And Newborn Health.

  2016cites this paper
• Pertussis: Biology, epidemiology and prevention.

  2016cites this paper
• Predicting future trends in the burden of pertussis in the 21st century: implications for infant pertussis and the success of maternal immunization

  2016cites this paper
• Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults

  2016cites this paper
• Estimated incidence of pertussis in people aged <50 years in the United States

  2016cites this paper
• New Challenges for Pertussis Vaccines

  2016cites this paper
• Pertussis specific cell-mediated immune responses ten years after acellular pertussis booster vaccination in young adults.

  2016cites this paper
• Old Disease and New Challenges: Major Obstacles of Current Strategies in the Prevention of Pertussis

  2016cites this paper
• Waning Tdap Effectiveness in Adolescents

  2016cites this paper
• Childhood Vaccine Exemption Policy: The Case for a Less Restrictive Alternative

  2016cites this paper
• Pertussis

  2016cites this paper
• Rediscovering Pertussis

  2016cites this paper
• Economic and Social Impact of Pertussis Among Adolescents in San Diego County.

  2016cites this paper
• Szczepienia – najlepsza metoda zwalczania groźnych chorób zakaźnych

  2016cites this paper
• Vaccine effectiveness of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine during a pertussis outbreak in Maine.

  2016cites this paper
• Bordetella pertussis

  2016cites this paper
• Immunization against pertussis in adolescents and adults.

  2016cites this paper
• Impact and cost-effectiveness of a second tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine dose to prevent pertussis in the United States.

  2016cites this paper
• An Assessment of the Cocooning Strategy for Preventing Infant Pertussis-United States, 2011.

  2016cites this paper
• Evolution and Efficacy of Pertactin-Deficient Pertussis Vaccination

  2016cites this paper
• Impact of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccinations on Reported Pertussis Cases Among Those 11 to 18 Years of Age in an Era of Waning Pertussis Immunity: A Follow-up Analysis.

  2016cites this paper
• Pertussis Vaccine Effectiveness in the Setting of Pertactin-Deficient Pertussis

  2016cites this paper
• T-cell immune responses to Bordetella pertussis infection and vaccination.

  2015cites this paper
• Differences in Pertussis Incidence by Income among Oregon Teens during an Outbreak

  2015cites this paper
• Strategies and new developments to control pertussis, an actual health problem.

  2015cites this paper
• Changing from whole-cell to acellular pertussis vaccines would trade superior tolerability for inferior protection

  2015cites this paper
• Defining long-term drivers of pertussis resurgence, and optimal vaccine control strategies.

  2015cites this paper
• Bordetella filamentous hemagglutinin and fimbriae: critical adhesins with unrealized vaccine potential.

  2015cites this paper
• Epidemic Pertussis and Acellular Pertussis Vaccine Failure in the 21st Century

  2015cites this paper
• The history of questionable fast tracked global HPV vaccination

  year unknowncites this paper